BR112023004563A2 - Composição para inibição da formação de placa - Google Patents

Composição para inibição da formação de placa

Info

Publication number
BR112023004563A2
BR112023004563A2 BR112023004563A BR112023004563A BR112023004563A2 BR 112023004563 A2 BR112023004563 A2 BR 112023004563A2 BR 112023004563 A BR112023004563 A BR 112023004563A BR 112023004563 A BR112023004563 A BR 112023004563A BR 112023004563 A2 BR112023004563 A2 BR 112023004563A2
Authority
BR
Brazil
Prior art keywords
composition
plaque formation
inhibition
plaque
inhibiting
Prior art date
Application number
BR112023004563A
Other languages
English (en)
Inventor
Inubushi Junya
Nishimura Keisuke
Original Assignee
Sunstar Suisse Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2020166440A external-priority patent/JP6968964B1/ja
Application filed by Sunstar Suisse Sa filed Critical Sunstar Suisse Sa
Publication of BR112023004563A2 publication Critical patent/BR112023004563A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIÇÃO PARA INIBIÇÃO DA FORMAÇÃO DE PLACA. É fornecido um meio para inibição da formação de placa sobre a superfície dental e a maturação de placas. Mais especificamente, é fornecida uma composição para inibição da formação de placas que contém um sal de amônio quaternário que tem um grupo C10 a C14 alquila e, de preferência, que contém ainda cloreto de cetilpiridínio.
BR112023004563A 2020-09-30 2021-09-30 Composição para inibição da formação de placa BR112023004563A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020166479 2020-09-30
JP2020166440A JP6968964B1 (ja) 2020-09-30 2020-09-30 プラーク形成抑制用組成物
PCT/JP2021/036034 WO2022071457A1 (ja) 2020-09-30 2021-09-30 プラーク形成抑制用組成物

Publications (1)

Publication Number Publication Date
BR112023004563A2 true BR112023004563A2 (pt) 2023-04-11

Family

ID=80951699

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023004563A BR112023004563A2 (pt) 2020-09-30 2021-09-30 Composição para inibição da formação de placa

Country Status (6)

Country Link
US (1) US20230372220A1 (pt)
EP (1) EP4223287A1 (pt)
CN (1) CN116249527A (pt)
BR (1) BR112023004563A2 (pt)
MX (1) MX2023003712A (pt)
WO (1) WO2022071457A1 (pt)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022880A (en) * 1973-09-26 1977-05-10 Lever Brothers Company Anticalculus composition
US4472373A (en) * 1983-05-09 1984-09-18 The Procter & Gamble Company Oral compositions
JPH1149625A (ja) * 1997-08-04 1999-02-23 Lion Corp 義歯安定剤組成物
US6350438B1 (en) * 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
JP2000256155A (ja) * 1999-03-09 2000-09-19 Sunstar Inc 口腔用組成物
JP2005117926A (ja) * 2003-10-15 2005-05-12 Lion Corp インビトロバイオフィルムおよび薬剤評価方法
WO2008010517A1 (fr) * 2006-07-20 2008-01-24 National University Corporation Okayama University Composition orale pour applications dentaires
JP5682283B2 (ja) * 2009-12-25 2015-03-11 ライオン株式会社 液体口腔用組成物
CN105792809B (zh) * 2013-12-27 2020-03-10 花王株式会社 口腔用组合物

Also Published As

Publication number Publication date
US20230372220A1 (en) 2023-11-23
CN116249527A (zh) 2023-06-09
WO2022071457A1 (ja) 2022-04-07
EP4223287A1 (en) 2023-08-09
MX2023003712A (es) 2023-04-24

Similar Documents

Publication Publication Date Title
MA42410B1 (fr) Oxystérols et leurs méthodes d'utilisation
MX2015012028A (es) Inhibidores de la ruta de quinurenina.
BR112018070677A2 (pt) inibidores de mcl-1 macrocíclicos para o tratamento de câncer
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
EA201650031A1 (ru) Производные пирролидин-2,5-диона, фармацевтические композиции и способы применения в качестве ингибиторов ido1
BR112014015402A2 (pt) composição sólida de cuidado pessoal, produto de cuidado pessoal e método de tratar cabelo e/ou pele
BR112015021352A2 (pt) composições antimicrobianas
BR112013016856A2 (pt) composto, uso de um composto, composição farmacêutica e produto farmacêutico
BR112018011210A2 (pt) métodos para inibir a conversão de carnitina em trimetilamina (tma)
BR112017009168A2 (pt) derivado de tionucleosídeo ou sal deste e composição farmacêutica
BR112018069712A2 (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a.
BR112015026478A2 (pt) derivados de dolastatina 10 e auristatinas
BR112013006654A2 (pt) composição oral
BR112022010638A2 (pt) Compostos para modular a atividade de fxr e usos dos mesmos
EA202092829A1 (ru) Композиции тофацитиниба с контролируемым высвобождением
BR112015026967A8 (pt) fenoxietil di-hidro-1h-isoquinolina, seus usos, e composição farmacêutica
BR112020008258B8 (pt) Compostos de biarila substituída ou seus sais farmaceuticamente aceitáveis, sua composição e seu uso como inibidores de indoleamina 2,3-dioxigenase (ido)
BR112012014196A2 (pt) agente para prevenir ou melhorar a pigmentação
BR112023004563A2 (pt) Composição para inibição da formação de placa
BR112019006087A2 (pt) composição de cuidados bucais e método para beneficiar dentes de um indivíduo
CL2017002367A1 (es) Composiciones solidas para el cuidado bucal
BR112016009811A2 (pt) derivado de carboximetil piperidina
BRPI0713743B8 (pt) composto, e, composição farmacêutica
MX2019011558A (es) Nuevos compuestos sustituidos de n'-hidroxicarbamimidoil-1,2,5-oxa diazol como inhibidores de indolamina 2,3-dioxigenasa (ido).
BR112017010740A2 (pt) ?composto, composição cosmética, utilização e método para o tratamento cosmético?